126 related articles for article (PubMed ID: 37003519)
1. Spinal dopaminergic D
De la Luz-Cuellar YE; Coffeen U; Mercado F; Granados-Soto V
Eur J Pharmacol; 2023 Jun; 948():175696. PubMed ID: 37003519
[TBL] [Abstract][Full Text] [Related]
2. Spinal dopaminergic D
De la Luz-Cuellar YE; Rodríguez-Palma EJ; Franco-Enzástiga Ú; Déciga-Campos M; Mercado F; Granados-Soto V
Brain Res; 2023 Jan; 1799():148167. PubMed ID: 36402178
[TBL] [Abstract][Full Text] [Related]
3. Estradiol modulates the role of the spinal α
Rodríguez-Palma EJ; Islas-Espinoza AM; Ramos-Rodríguez II; Pizaña-Encarnación JM; Gutiérrez-Agredano MÁ; Morales-Moreno C; Fernández-Guasti A; Granados-Soto V
Eur J Pharmacol; 2024 Jul; 974():176616. PubMed ID: 38679122
[TBL] [Abstract][Full Text] [Related]
4. Blockade of spinal α
De la Luz-Cuellar YE; Rodríguez-Palma EJ; Franco-Enzástiga Ú; Salinas-Abarca AB; Delgado-Lezama R; Granados-Soto V
Eur J Pharmacol; 2019 Sep; 858():172443. PubMed ID: 31181208
[TBL] [Abstract][Full Text] [Related]
5. Anxiolytic-like effect of quinpirole in combination with a low dose of 17β-estradiol in ovariectomized rats.
Fedotova J
Acta Physiol Hung; 2013 Jun; 100(2):211-23. PubMed ID: 23708948
[TBL] [Abstract][Full Text] [Related]
6. [Administration of quinpirole with 17beta-estradiol in low doses corrects active avoidance performance in ovariectomized female rats].
Fedotova IuO; Sapronov NS
Eksp Klin Farmakol; 2012; 75(12):7-10. PubMed ID: 23700659
[TBL] [Abstract][Full Text] [Related]
7. Sex-dependent antiallodynic effect of α
Rodríguez-Palma EJ; Castelo-Flores DG; Caram-Salas NL; Salinas-Abarca AB; Centurión D; De la Luz-Cuellar YE; Granados-Soto V
Eur J Pharmacol; 2022 Apr; 920():174855. PubMed ID: 35227682
[TBL] [Abstract][Full Text] [Related]
8. Lesions of the nigrostriatal dopamine projection increase the inhibitory effects of D1 and D2 dopamine agonists on caudate-putamen neurons and relieve D2 receptors from the necessity of D1 receptor stimulation.
Hu XT; Wachtel SR; Galloway MP; White FJ
J Neurosci; 1990 Jul; 10(7):2318-29. PubMed ID: 1973947
[TBL] [Abstract][Full Text] [Related]
9. Reserpine increases Fos activity in the rat basal ganglia via a quinpirole-sensitive mechanism.
Cole DG; Di Figlia M
Neuroscience; 1994 May; 60(1):115-23. PubMed ID: 7914358
[TBL] [Abstract][Full Text] [Related]
10. The cannabinoid receptor agonist WIN 55,212-2 reduces D2, but not D1, dopamine receptor-mediated alleviation of akinesia in the reserpine-treated rat model of Parkinson's disease.
Maneuf YP; Crossman AR; Brotchie JM
Exp Neurol; 1997 Nov; 148(1):265-70. PubMed ID: 9398468
[TBL] [Abstract][Full Text] [Related]
11. Dopamine supersensitivity and D1/D2 synergism are unrelated to changes in striatal receptor density.
LaHoste GJ; Marshall JF
Synapse; 1992 Sep; 12(1):14-26. PubMed ID: 1357762
[TBL] [Abstract][Full Text] [Related]
12. Sex differences and estradiol involvement in hyperalgesia and allodynia in an experimental model of fibromyalgia.
Hernandez-Leon A; De la Luz-Cuellar YE; Granados-Soto V; González-Trujano ME; Fernández-Guasti A
Horm Behav; 2018 Jan; 97():39-46. PubMed ID: 29080671
[TBL] [Abstract][Full Text] [Related]
13. Effects of acute dopamine depletion on responsiveness to D1 and D2 receptor agonists in infant and weanling rat pups.
Moody CA; Spear LP
Psychopharmacology (Berl); 1992; 107(1):39-49. PubMed ID: 1350350
[TBL] [Abstract][Full Text] [Related]
14. Striatal Fos expression is indicative of dopamine D1/D2 synergism and receptor supersensitivity.
LaHoste GJ; Yu J; Marshall JF
Proc Natl Acad Sci U S A; 1993 Aug; 90(16):7451-5. PubMed ID: 8102797
[TBL] [Abstract][Full Text] [Related]
15. Involvement of D1 receptors in depression-like behavior of ovariectomized rats.
Fedotova J; Ordyan N
Acta Physiol Hung; 2011 Jun; 98(2):165-76. PubMed ID: 21616775
[TBL] [Abstract][Full Text] [Related]
16. Electrophysiological effects of SKF 38393 in rats with reserpine treatment and 6-hydroxydopamine-induced nigrostriatal lesions reveal two types of plasticity in D1 dopamine receptor modulation of basal ganglia output.
Huang KX; Walters JR
J Pharmacol Exp Ther; 1994 Dec; 271(3):1434-43. PubMed ID: 7996456
[TBL] [Abstract][Full Text] [Related]
17. Nigral D1 and striatal D2 receptors mediate the behavioral effects of dopamine agonists.
LaHoste GJ; Marshall JF
Behav Brain Res; 1990 May; 38(3):233-42. PubMed ID: 1973041
[TBL] [Abstract][Full Text] [Related]
18. Role of D1 and D2 dopamine receptors in mediating locomotor activity elicited from the nucleus accumbens of rats.
Dreher JK; Jackson DM
Brain Res; 1989 May; 487(2):267-77. PubMed ID: 2525062
[TBL] [Abstract][Full Text] [Related]
19. Why does clozapine stimulate the motor activity of reserpine-pretreated rats when combined with a dopamine D1 receptor agonist?
Jackson DM; Mohell N; Bengtsson A; Malmberg A
Eur J Pharmacol; 1995 Aug; 282(1-3):137-44. PubMed ID: 7498268
[TBL] [Abstract][Full Text] [Related]
20. A within-subjects microdialysis/behavioural study of the role of striatal acetylcholine in D1-dependent turning.
Acquas E; Fenu S; Loddo P; Di Chiara G
Behav Brain Res; 1999 Sep; 103(2):219-28. PubMed ID: 10513590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
